Cucurbitacin B causes increased radiation sensitivity of human breast cancer cells via G2/M cell cycle arrest

Purpose. To explore the effects of cucurbitacin B on the radiation survival of human breast cancer cells and to elucidate the cellular mechanism of radiosensitization if any. Materials and Methods. Human breast carcinoma cell lines were treated with cucurbitacin B before irradiation with 0–10Gy of...

Full description

Saved in:
Bibliographic Details
Main Authors: Suwit Duangmano, Phorntip Sae-lim, Apichart Suksamrarn, Pimpichaya Patmasiriwat, Frederick E. Domann
Format: Article
Language:English
Published: Mahidol University. Faculty of Medical Technology 2013
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/2100
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
Language: English
Description
Summary:Purpose. To explore the effects of cucurbitacin B on the radiation survival of human breast cancer cells and to elucidate the cellular mechanism of radiosensitization if any. Materials and Methods. Human breast carcinoma cell lines were treated with cucurbitacin B before irradiation with 0–10Gy of 137Cs gamma rays. The effect of cucurbitacin B on cell-survival following irradiation was evaluated by colony-forming assay. Cell cycle distributions were investigated using flow cytometry. Real-time PCR and western blots were performed to investigate the expression of cell cycle checkpoints. Results. Cucurbitacin B inhibited breast cancer cell proliferation in a dose-dependent manner. Only MDA-MB-231 and MCF7:5C cells but not SKBR-3 cells were radiosensitized by cucurbitacin B. Flow cytometric analysis for DNA content indicated that cucurbitacin B resulted in G2/M arrest in MDA-MB-231 andMCF7:5C but not SKBR-3 cells.Moreover, Real-time PCR and western blot analysis demonstrated upregulated p21 expression before irradiation, a likely cause of the cell cycle arrest. Conclusion. Taken together, these findings suggest that cucurbitacin B causes radiosensitization of some breast cancer cells, and that cucurbitacin B induced G2/M arrest is an importantmechanism. Therefore, combinations of cucurbitacin B with radiotherapy may be appropriate for experimental breast cancer treatment.